HMOX1型
血红素
细胞生物学
铁蛋白
细胞内
功能(生物学)
化学
程序性细胞死亡
癌症研究
生物
信号转导
癌细胞
细胞
GPX4
分解代谢
胆绿素
下调和上调
活性氧
血红素加氧酶
细胞培养
遗传筛选
生物化学
癌症
HEK 293细胞
细胞功能
作者
Izadora de Souza,Izabela Amélia Marques de Andrade,Florêncio Porto Freitas,Ana Beatriz da Silva Teixeira,Maria Carolina Clares Ramalho,Karoline Almeida,Ancély Ferreira dos Santos,Werner Schmitz,Gholamreza Fazeli,Clarissa Ribeiro Reily Rocha,José Pedro Friedmann Angeli
出处
期刊:Science Advances
[American Association for the Advancement of Science]
日期:2026-08-19
卷期号:12 (34): eaeg3424-eaeg3424
被引量:3
标识
DOI:10.1126/sciadv.aeg3424
摘要
Modulating the intracellular labile iron pool (LIP) has emerged as a promising strategy to induce ferroptosis in cancer cells, offering a way to overcome resistance to apoptosis-based therapies. One of the main contributors to LIP is heme catabolism mediated by heme oxygenase-1 (HMOX1), which promotes ferroptosis sensitivity by releasing free iron. Beyond its role as an iron donor, heme can influence diverse proteins and signaling pathways that drive tumor progression, but how heme regulates ferroptosis remains poorly understood. Here, we uncover a paradoxical, protective function of heme in the absence of HMOX1 activity. When HMOX1 is inactive, heme becomes stabilized, leading to ferritin up-regulation, suppression of ferroptosis, and rescue of cell death induced by both pharmacological and genetic inhibition of GPX4. Our findings reveal an unrecognized heme-HMOX1-ferritin axis that controls ferroptosis sensitivity. Targeting this pathway may offer a new therapeutic strategy to modulate ferroptosis in cancer.
科研通智能强力驱动
Strongly Powered by AbleSci AI